COMPARISON BETWEEN SHORT-LASTING LEVOTHYROXINE WITHDRAWAL AND RECOMBINANT HUMAN THYROTROPIN IN THE POSTSURGICAL FOLLOW-UP OF LOW-RISK DIFFERENTIATED THYROID CARCINOMA